Skip to main content

Hydroquinone 4%

Generic: Hydroquinone

Verified·Apr 23, 2026
NDC
50405-800
RxCUI
197795
Route
TOPICAL
ICD-10 indication
L81.1

Affordability Check

How much will you actually pay for Hydroquinone 4%?

In 30 seconds, see every legitimate way to afford Hydroquinone 4% — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Hydroquinone 4%

What is this medication? Hydroquinone 4 percent is a prescription-strength topical cream used to treat various types of skin discoloration. It is primarily indicated for lightening dark patches of skin, such as melasma, age spots, liver spots, and freckles caused by sun exposure, hormonal changes, or skin injuries. This concentration is stronger than over-the-counter versions and is designed to target stubborn areas of hyperpigmentation by interfering with the biological processes that cause darkening. The medication functions as a skin-bleaching agent by inhibiting the activity of tyrosinase, the enzyme responsible for producing melanin. By slowing down the production of this pigment, the dark areas gradually fade over time to match the surrounding skin. It is typically applied to specific spots once or twice a day, and it is crucial to use sunscreen while using this product, as sun exposure can trigger new pigment production and reverse the results of the treatment.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Hydroquinone 4%. Official source: DailyMed (NLM) · Label effective Jun 5, 2023

Indications and usage
INDICATIONS AND USAGE Hydroquinone USP, 4% Skin Bleaching Cream is indicated for the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation.
Dosage and administration
DOSAGE AND ADMINISTRATION Hydroquinone USP, 4% Skin Bleaching Cream should be applied to affected areas and rubbed in well twice daily, in the morning and before bedtime, or as directed by a physician. If no improvement is seen after 2 months of treatment, use of this product should be discontinued. There is no recommended dosage for pediatric patients under 12 years of age except under the advice and supervision of a physician.
Contraindications
CONTRAINDICATIONS Prior history of sensitivity or allergic reaction to hydroquinone or to any of the ingredients of the product. The safety of topical hydroquinone use during pregnancy or for children (12 years and under) has not been established.
Warnings
WARNINGS Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions, including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in non-asthmatic people. Since this product contains no sunscreen, an effective broad spectrum sun-blocking agent should be used and unnecessary solar exposure avoided, or protective clothing should be worn to cover bleached skin in order to prevent repigmentation from occurring. Hydroquinone may produce exogenous ochronosis, a gradual blue-black darkening of the skin. If this condition occurs, discontinue treatment and consult your physician. The majority of patients developing this condition are Black, but it may also occur in Caucasians and Hispanics.
Adverse reactions
ADVERSE REACTIONS The following adverse reactions have been reported: dryness and fissuring of paranasal and intraorbital areas, erythema, and stinging. Occasional hypersensitivity (localized contact dermatitis) may develop. If this occurs, the medication should be discontinued and the physician notified immediately.
Use in pregnancy
Pregnancy Teratogenic Effects Pregnancy Category C Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether topical hydroquinone can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Topical hydroquinone should be given to a pregnant woman only if clearly needed.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.